Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
16659 Southwest Freeway
Suite 131
Sugar Land, TX 77479Phone+1 281-276-5200Fax+1 281-276-5201- Is this information wrong?
Summary
- Dr. Sindhu Nair is an oncologist in Sugar Land, TX and is affiliated with multiple hospitals in the area, including Houston Methodist Sugar Land Hospital, Houston Methodist West Hospital, and Houston Methodist Hospital. She received her medical degree from Baylor College of Medicine and has been in practice 13 years. She specializes in hematologic oncology and is experienced in thoracic cancer, gastrointestinal cancer, colorectal cancer, hematologic oncology, breast cancer, gynecologic cancers and cancer genetics. She also specializes in benign hematology.
Education & Training
- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
- Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007
- Baylor College of MedicineClass of 2004
Certifications & Licensure
- TX State Medical License 2009 - 2025
- PA State Medical License 2008 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer Start of enrollment: 2019 Apr 05
- A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) Start of enrollment: 2022 Aug 03
Publications & Presentations
PubMed
- 3 citationsA Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupt...> ;Clinical Cancer Research. 2022 Oct 14
- 5 citationsANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li, Pej Hemati, Helen Wong, Wei Qian, Toniva Boone, Jing Zhao, Priya V. Ramshesh, Adam L. Cohen, Asha Mu...> ;Breast Cancer Research and Treatment. 2021 Apr 15
Press Mentions
- Beat the Pack’ Program to Help People Quit Smoking Offered at Houston Methodist Sugar Land HospitalNovember 14th, 2019
- Colorectal Cancer Seminar Fighting Rare, Genetic Colorectal CancerFebruary 2nd, 2017
Professional Memberships
- Member
- Member
- Member
- Member
Hospital Affiliations
- Houston Methodist HospitalHouston, Texas
- Houston Methodist Sugar Land HospitalSugar Land, Texas
- Houston Methodist Clear Lake HospitalHouston, Texas
- Houston Methodist Baytown HospitalBaytown, Texas
- Houston Methodist The Woodlands HospitalConroe, Texas
- Houston Methodist West HospitalHouston, Texas
- Houston Methodist Willowbrook HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: